353 related articles for article (PubMed ID: 33530627)
1. Understanding Host Immunity and the Gut Microbiota Inspires the New Development of Vaccines and Adjuvants.
Yakabe K; Uchiyama J; Akiyama M; Kim YG
Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33530627
[TBL] [Abstract][Full Text] [Related]
2. Utilization of gut environment-mediated control system of host immunity in the development of vaccine adjuvants.
Liu Z; Hosomi K; Kunisawa J
Vaccine; 2022 Aug; 40(36):5399-5403. PubMed ID: 35918205
[TBL] [Abstract][Full Text] [Related]
3. Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations.
Sánchez-Ramón S; Conejero L; Netea MG; Sancho D; Palomares Ó; Subiza JL
Front Immunol; 2018; 9():2936. PubMed ID: 30619296
[TBL] [Abstract][Full Text] [Related]
4. Influence of Microbiota on Vaccine Effectiveness: "Is the Microbiota the Key to Vaccine-induced Responses?".
Hong SH
J Microbiol; 2023 May; 61(5):483-494. PubMed ID: 37052795
[TBL] [Abstract][Full Text] [Related]
5. β-Glucan as Trained Immunity-Based Adjuvants for Rabies Vaccines in Dogs.
Paris S; Chapat L; Martin-Cagnon N; Durand PY; Piney L; Cariou C; Bergamo P; Bonnet JM; Poulet H; Freyburger L; De Luca K
Front Immunol; 2020; 11():564497. PubMed ID: 33162977
[TBL] [Abstract][Full Text] [Related]
6. The next generation of HCV vaccines: a focus on novel adjuvant development.
Kardani K; Sadat SM; Kardani M; Bolhassani A
Expert Rev Vaccines; 2021 Jul; 20(7):839-855. PubMed ID: 34114513
[TBL] [Abstract][Full Text] [Related]
7. Feed, Microbiota, and Gut Immunity: Using the Zebrafish Model to Understand Fish Health.
López Nadal A; Ikeda-Ohtsubo W; Sipkema D; Peggs D; McGurk C; Forlenza M; Wiegertjes GF; Brugman S
Front Immunol; 2020; 11():114. PubMed ID: 32117265
[TBL] [Abstract][Full Text] [Related]
8. Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy.
Kazemifard N; Dehkohneh A; Baradaran Ghavami S
Front Med (Lausanne); 2022; 9():940454. PubMed ID: 36313997
[TBL] [Abstract][Full Text] [Related]
9. Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants.
Reinke S; Thakur A; Gartlan C; Bezbradica JS; Milicic A
Vaccines (Basel); 2020 Sep; 8(3):. PubMed ID: 32971761
[TBL] [Abstract][Full Text] [Related]
10. Innovative Vaccine Strategy: Self-Adjuvanting Conjugate Vaccines.
Manabe Y; Fukase K
Methods Mol Biol; 2023; 2613():55-72. PubMed ID: 36587070
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines.
Hong M; Lan T; Li Q; Li B; Yuan Y; Xu F; Wang W
Gut Microbes; 2023; 15(1):2233146. PubMed ID: 37431857
[TBL] [Abstract][Full Text] [Related]
12. Integrative analyses of probiotics, pathogenic infections and host immune response highlight the importance of gut microbiota in understanding disease recovery in rainbow trout (Oncorhynchus mykiss).
Rasmussen JA; Villumsen KR; von Gersdorff Jørgensen L; Forberg T; Zuo S; Kania PW; Buchmann K; Kristiansen K; Bojesen AM; Limborg MT
J Appl Microbiol; 2022 Apr; 132(4):3201-3216. PubMed ID: 35032344
[TBL] [Abstract][Full Text] [Related]
13. Do the Microbiota Influence Vaccines and Protective Immunity to Pathogens? Engaging Our Endogenous Adjuvants.
Collins N; Belkaid Y
Cold Spring Harb Perspect Biol; 2018 Feb; 10(2):. PubMed ID: 28432130
[TBL] [Abstract][Full Text] [Related]
14. Modes of Action for Mucosal Vaccine Adjuvants.
Aoshi T
Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic adjuvants: durable reprogramming of the innate immune system with adjuvants.
Lee A; Wimmers F; Pulendran B
Curr Opin Immunol; 2022 Aug; 77():102189. PubMed ID: 35588691
[TBL] [Abstract][Full Text] [Related]
16. Targeting gut microbiota for immunotherapy of diseases.
Yu YJ; Liu XD; Liao C; Yu R; Wang X; Li M; Wang Y
Arch Toxicol; 2024 May; ():. PubMed ID: 38722348
[TBL] [Abstract][Full Text] [Related]
17. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
Leroux-Roels G
Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
[TBL] [Abstract][Full Text] [Related]
18. The early-life gut microbiome and vaccine efficacy.
Jordan A; Carding SR; Hall LJ
Lancet Microbe; 2022 Oct; 3(10):e787-e794. PubMed ID: 36088916
[TBL] [Abstract][Full Text] [Related]
19. Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity.
Ng HY; Leung WK; Cheung KS
Microorganisms; 2023 Feb; 11(2):. PubMed ID: 36838417
[TBL] [Abstract][Full Text] [Related]
20. Probiotic Lactobacillus rhamnosus GG enhanced Th1 cellular immunity but did not affect antibody responses in a human gut microbiota transplanted neonatal gnotobiotic pig model.
Wen K; Tin C; Wang H; Yang X; Li G; Giri-Rachman E; Kocher J; Bui T; Clark-Deener S; Yuan L
PLoS One; 2014; 9(4):e94504. PubMed ID: 24722168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
